These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8011544)

  • 1. Recombinant human erythropoietin in autologous blood donors: a dose-finding study.
    Biesma DH; Kraaijenhagen RJ; Dalmulder J; Marx JJ; Van De Wiel A
    Br J Haematol; 1994 Jan; 86(1):30-5. PubMed ID: 8011544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy-induced anemia in autologous blood donors.
    Biesma DH; Kraaijenhagen RJ; Marx JJ; van de Wiel A
    Transfusion; 1993 Oct; 33(10):825-9. PubMed ID: 8236423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
    Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
    Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin in the treatment of cancer-related anaemia.
    Kasper C; Terhaar A; Fosså A; Welt A; Seeber S; Nowrousian MR
    Eur J Haematol; 1997 Apr; 58(4):251-6. PubMed ID: 9186536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery.
    Schmoeckel M; Nollert G; Mempel M; Mempel W; Reichart B
    Thorac Cardiovasc Surg; 1993 Dec; 41(6):364-8. PubMed ID: 8128466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin.
    Biesma DH; Marx JJ; Kraaijenhagen RJ; Franke W; Messinger D; van de Wiel A
    Lancet; 1994 Aug; 344(8919):367-70. PubMed ID: 7914307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
    Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
    Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery.
    Madi-Jebara SN; Sleilaty GS; Achouh PE; Yazigi AG; Haddad FA; Hayek GM; Antakly MC; Jebara VA
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):59-63. PubMed ID: 14973801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapy.
    Goodnough LT; Price TH; Parvin CA; Friedman KD; Vogler WR; Khan N; Sacher R; Johnston M; Wissel M; Ciavarella D
    Br J Haematol; 1994 Aug; 87(4):695-9. PubMed ID: 7986708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia.
    Breymann C; Zimmermann R; Huch R; Huch A
    Eur J Clin Invest; 1996 Feb; 26(2):123-30. PubMed ID: 8904521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron and erythropoietin measurement in autologous blood donors with anemia: implications for management.
    Tasaki T; Ohto H; Noguchi M; Motoki R; Kikuchi S; Sato A; Hoshino S
    Transfusion; 1994 Apr; 34(4):337-43. PubMed ID: 8178331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of high dose therapy of rhEPO, given two or three times a week in premature infants.
    Bock W; Gröhs B; Minihold B; Schemper M; Lischka A
    J Perinat Med; 1995; 23(1-2):133-8. PubMed ID: 7658314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients.
    Charuruks N; Voravud N; Limpanasithikul W
    J Clin Lab Anal; 2001; 15(5):260-6. PubMed ID: 11574955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO).
    Rau B; Schlag PM; Willeke F; Herfarth C; Stephan P; Franke W
    Eur J Cancer; 1998 Jun; 34(7):992-8. PubMed ID: 9849445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study.
    Beris P; Mermillod B; Levy G; Laubriat M; Soulier-Lauper M; Tullen E; Hugli A; Miescher PA
    Vox Sang; 1993; 65(3):212-8. PubMed ID: 8249364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.
    Barosi G; Merlo C; Palestra P; Liberato NL; Guarnone R; Di Dio F; Piazza V; Salvadeo A
    Acta Haematol; 1993; 90(1):13-8. PubMed ID: 8237268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
    Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
    Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
    ten Bokkel Huinink WW; de Swart CA; van Toorn DW; Morack G; Breed WP; Hillen HF; van der Hoeven JJ; Reed NS; Fairlamb DJ; Chan SY; Godfrey KA; Kristensen GB; van Tinteren H; Ehmer B
    Med Oncol; 1998 Sep; 15(3):174-82. PubMed ID: 9819794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.